Science
Mechanism of Action
This ingredient is hypothesized to exert its primary effects through the Glycitein moiety, a phytoestrogen with significant antioxidant capacity, neutralizing harmful free radicals. It also demonstrates anti-inflammatory actions by modulating key cellular signaling pathways, including Nrf2-ARE and NF-κB, and interacts with estrogen receptors. The covalently attached Palmitoyl group, a saturated fatty acid, is designed to increase the molecule's lipophilicity, thereby facilitating its absorption into the skin and optimizing its delivery.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The presence of the Palmitoyl group is anticipated to significantly enhance the stability of Glycitein, particularly within oil-based formulations, by increasing its lipophilicity. Unmodified Glycitein demonstrates limited aqueous solubility and is susceptible to degradation from prolonged exposure to water or air, often requiring storage under an inert gas.
Safety
Safety Profile
As a distinct chemical entity, PALMITOYL GLYCITEIN has not been specifically reviewed by the Cosmetic Ingredient Review (CIR) Expert Panel. While Glycitein is a component of many soy-derived ingredients, a 2019 CIR report noted insufficient data for specific soy compounds regarding composition, purity, dermal toxicity, and sensitization. The absence of reported uses in the FDA's Voluntary Cosmetic Registration Program (VCRP) further limits its safety assessment.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to a complete absence of specific clinical studies, safety assessments, and detailed formulation guidelines for PALMITOYL GLYCITEIN, its precise efficacy and safety profile remain largely theoretical and warrant extensive dedicated research.
Related
Similar Ingredients
Finding similar ingredients…